DOWNERS
GROVE, Ill., Jan. 29,
2025 /PRNewswire/ -- CPC (Colder Products Company),
part of Dover (NYSE: DOV) and a leading manufacturer of
connection technologies used in biopharmaceutical processing, today
announced the launch of its new MicroCNX® Nano Series aseptic
connectors, designed to significantly simplify cell and gene
therapy (CGT) closed sterile processing.
"Cell and gene therapy is advancing quickly, but the industry
relies on older, cumbersome techniques like biosafety cabinets or
tube welding for sterile processing," said Troy Ostreng, Senior Product Manager for CPC's
biopharmaceutical business. "Now, CGT processing assemblies that
include the MicroCNX Nano connectors will allow users to easily
click together the connector halves to create a sterile flow path.
This is a major advancement for CGT applications."
CGT manufacturers currently rely on 1/8- and 1/16-inch flow
paths to move cells efficiently, with minimal turbulence, and to
help reduce holdup volume, which occurs when liquid is trapped in
the tubing and cannot easily be recovered. Tube welding requires
extra tubing on either side of the weld, which is a source of
holdup volume. The MicroCNX Nano Series does not require extra
tubing, and the connectors can be quickly joined outside of a
biosafety cabinet.
The MicroCNX Nano connector's small size also allows it to fit
directly into the freeze cassettes used in CGT product
cryopreservation. The connectors can be frozen to -190°C, which
supports cell health during storage and transport.
"We believe small-format aseptic connectors are the future of
CGT sterile processing," said Ostreng. "MicroCNX Series products
offer a faster, more efficient approach to creating sterile closed
systems. "
This new series builds on CPC's pioneering work in creating the
industry's smallest aseptic connectors, which are designed
specifically to handle CGT's small fluid volumes.
For more information about the performance and versatility of
the MicroCNX Series connectors or any of the other innovative
connection solutions CPC offers, visit cpcworldwide.com/micro.
About CPC:
CPC (Colder Products
Company) is the leader in single-use connection
technology, offering a wide variety of connectors for
manufacturing in biopharmaceuticals, cell therapy, and gene
therapy. The company's innovative, flexible products enable users
to easily combine multiple components and systems including process
containers, tubing manifolds, transfer lines, bioreactors and other
bioprocess equipment. Robust single-use connectors maintain media
sterility and integrity while improving production yields,
decreasing time to market and reducing costs. The company's
well-known AseptiQuik® connectors provide
quick and easy sterile connections even in non-sterile
environments. Learn more at cpcworldwide.com/bio. Connect with
confidence with CPC, an operating company within Dover
Corporation.
About Dover:
Dover is a diversified global manufacturer and solutions
provider with annual revenue of over $7
billion. We deliver innovative equipment and components,
consumable supplies, aftermarket parts, software and digital
solutions, and support services through five operating segments:
Engineered Products, Clean Energy & Fueling, Imaging &
Identification, Pumps & Process Solutions and Climate &
Sustainability Technologies. Dover combines global scale with
operational agility to lead the markets we serve. Recognized for
our entrepreneurial approach for over 70 years, our team of
approximately 24,000 employees takes an ownership mindset,
collaborating with customers to redefine what's possible.
Headquartered in Downers Grove,
Illinois, Dover trades on the New York Stock Exchange under
"DOV." Additional information is available at
dovercorporation.com.
CPC Contact:
Jana Stender
(612) 564-2053
jana.stender@cpcworldwide.com
Dover Media Contact:
Adrian Sakowicz, VP,
Communications
(630) 743-5039
asakowicz@dovercorp.com
Dover Investor Contact:
Jack
Dickens, VP, Investor Relations
(630) 743-2566
jdickens@dovercorp.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cpc-launches-industry-first-product-for-cell-and-gene-therapy-sterile-processing-302363505.html
SOURCE Dover
